Title:
非定型抗精神病薬およびmGLU2/3受容体アゴニストを組み合わせた精神病治療
Document Type and Number:
Japanese Patent JP2005528378
Kind Code:
A
Abstract:
The present invention provides for a pharmaceutical composition and methods for treating psychosis comprising the combination or a first component which is an atypical antipsychotic with a second component which is a mGlu2/3 receptor agonist. The present invention also provides for a pharmaceutical composition and method of treating a psychiatric disorder comprising the combination of a first component which is an atypical antipsychotic with a second component which is a compound which allosterically enhances receptor activity for mGlu2 and/or mGlu3.
Inventors:
Brian Glen Johnson
Darryl Darwin Scope
Darryl Darwin Scope
Application Number:
JP2003581846A
Publication Date:
September 22, 2005
Filing Date:
March 21, 2003
Export Citation:
Assignee:
ELI LILLY AND COMPANY
International Classes:
C07D243/38; A61K31/196; A61K31/343; A61K31/551; A61K31/5513; A61K38/00; A61K45/06; A61P25/18; C07D307/93; C07D495/04; (IPC1-7): A61K45/06; A61K31/196; A61K31/343; A61K31/551; A61K31/5513; A61K38/00; A61P25/18
Attorney, Agent or Firm:
Kyousei Tamura
Hiromitsu Takayama
Minato Saito
Hiromitsu Takayama
Minato Saito